These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 466976)

  • 41. [Changes in blood clotting and fibrinolysis systems in man after angiography with Uropolinum "Polfa" (author's transl)].
    Szmigielski W; Modzelewska M; Jakubowska M; Szczerbo-Trojanowska M
    Pol Przegl Radiol Med Nukl; 1976; 40(1):43-6. PubMed ID: 1272911
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of Ciprofibrate on platelet aggregation and fibrinolysis in patients with hypercholesterolaemia.
    Simpson IA; Lorimer AR; Walker ID; Davidson JF
    Thromb Haemost; 1985 Aug; 54(2):442-4. PubMed ID: 4082082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Azidofibrate. Synthesis and evaluation of its effects on fat cell lipolysis in vitro.
    Gaion RM; Pozzo-Balbi T; Nobile L; Da Re P
    Arzneimittelforschung; 1982; 32(3):186-9. PubMed ID: 7200777
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of Trasylol on blood coagulation and fibrinolysis after intravenous injection.
    Gormsen J
    Acta Chir Scand Suppl; 1967; 378():53-61. PubMed ID: 4966132
    [No Abstract]   [Full Text] [Related]  

  • 45. On thrombosis, thrombolysis and fibrinolysis. I. Thrombolytic therapy of deep venous thrombosis. II. Assay of individual fibrinolytic response.
    Robertson BR
    Acta Chir Scand Suppl; 1971; 421():1-51. PubMed ID: 5292287
    [No Abstract]   [Full Text] [Related]  

  • 46. [Activation of fibrinolysis after oral administration of D-glucitol-hexanicotinate. Preliminary data].
    Pinto A; Novo S; Avellone G; Vinci G
    Boll Soc Ital Cardiol; 1978; 23(4):641-5. PubMed ID: 757348
    [No Abstract]   [Full Text] [Related]  

  • 47. Clinical trials of plafibride in geriatric patients.
    Demichelis Genesio MA; Bracons R; Vicens B; Zapatero J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1852-5. PubMed ID: 7198465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of various therapeutic agents on hemorrhagic diathesis and blood clotting factors in aged patients with cerebrovascular disorders].
    Hidaka T
    Nihon Ika Daigaku Zasshi; 1972 Jan; 39(1):60-71. PubMed ID: 5040431
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of ethanol on human blood fibrinolysis and coagulation.
    Olsen H; Osterud B
    Alcohol Alcohol Suppl; 1987; 1():591-4. PubMed ID: 3426737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in some blood clotting and fibrinolysis factors during anaesthesia with neuroleptanalgesic agents.
    Referowska M
    Anaesth Resusc Intensive Ther; 1975; 3(2):141-6. PubMed ID: 1180372
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of submaximal physical exertion on serum lipid levels and the blood coagulation and fibrinolysis systems in patients with arteriosclerosis].
    Markiewicz K; Cholewa M; Jazdzewski B; Gawor Z
    Pol Tyg Lek; 1984 Jun 12-25; 39(25-26):857-61. PubMed ID: 6494044
    [No Abstract]   [Full Text] [Related]  

  • 52. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
    Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Blood coagulation in halothane anesthesia--effect on fibrinolysis].
    Oyama C; Takiguchi M; Hasegawa T; Hagasewa K; Kobe K
    Masui; 1967 Sep; 16(9):686-91. PubMed ID: 5626499
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of drug preparations used in treating coronary arteriosclerosis on the coagulogram and blood biochemical indices].
    Semavin IE; Goliakov VN; Semiletov VI; Solov'ev VV
    Sov Med; 1979 Jan; (1):31-5. PubMed ID: 424857
    [No Abstract]   [Full Text] [Related]  

  • 55. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of nicotinic acid and miskleron on the lipid spectrum in chronic kidney failure].
    Pyrig LA; Petrun' NM; Mel'man NIa; Nikulina GG; Shinkarenko NR
    Urol Nefrol (Mosk); 1981; (3):42-5. PubMed ID: 7268975
    [No Abstract]   [Full Text] [Related]  

  • 57. [Behavior of some components of the clotting and fibrinolytic systems during general anesthesia using ether and halothane].
    Jastrzebski J
    Pol Przegl Chir; 1972 Apr; 44(4):643-8. PubMed ID: 5026136
    [No Abstract]   [Full Text] [Related]  

  • 58. [The effect of angiography on the blood coagulation and fibrinolysis system].
    Krause WH; Lang A
    Verh Dtsch Ges Inn Med; 1978; (84):1348-50. PubMed ID: 741963
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
    Laursen B; Gormsen J
    Scand J Haematol; 1969; 6(6):402-8. PubMed ID: 5374117
    [No Abstract]   [Full Text] [Related]  

  • 60. [Bio-hematological tolerance of isonixine in healthy persons].
    Serra Mercader JM; Paso Luna M; Berga Casafont L; Fuentes Arderiu J; Mitjavila Cors MT
    Rev Esp Reum Enferm Osteoartic; 1978; 21(3):227-42. PubMed ID: 362495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.